BAYER has released Novalac Allergy, claimed to be "Australia's only 100% rice protein-based formula for infants with cow's milk protein allergy (CMPA)".
Novalac Allergy reduced a combination of allergy symptoms by 74.1% after one month and 88.9% by the sixth month according to a study published in the European Journal of Paediatrics.
The study revealed that significant improvements in weight gain were demonstrated after the first month of using Novalac Allergy, helping to normalise weight after six months.
In Australia and New Zealand, CMPA is the most common of childhood food allergies, affecting approximately 1 in 50 babies.
The condition peaks in the first year of the infant's life, with more than 80% of CMPA cases resolved by the age of five.
Symptoms of CMPA commonly develop within the first week of exposure to cow's milk in the infant's diet, which may include a rash (eczema or hives), swelling, vomiting, diarrhoea, wheezing and poor growth.
Medical Director of Allergy Medical Professor Pete Smith, says Novalac Allergy is a welcome alternative for children with CMPA.
Bayer advises that professional advice should always be followed before using an infant formula.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Oct 16
